Clinical Trial Update: Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the WATCHMAN left atrial appendage closure device to long-term warfarin therapy in patients with atrial fibrillation; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• WATCHMAN Left Atrial Appendage Closure Device (Left atrial appendage closure device)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Fibrillation, Stroke | Phase 3 | Status: COMPLETED | Results posted: 2018-07-26